NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Taichu Group

Taichu Group

Private
ShanghaiHealthcare & Life Scienceshttps://www.taichubio.com/

Last Round

Series B

Mar 1, 2025

Total Funding Raised

$101.3M

Company Overview

Taichu Group is a biotechnology company that provides an integrated contract research, development, and manufacturing organization (CRDMO) platform for preclinical drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

Contract Research OrganizationCROContract Development and Manufacturing OrganizationCDMOIntegrated CRO CDMOBiologics CDMODrug discovery servicesPreclinical researchAntibody discoveryGMP manufacturingNucleic acid drug developmentOligonucleotide CDMOBiopharmaceutical services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Taichu Group Comparables

Compare Taichu Group with similar companies based on industry and business-model similarity.

Taichu Group comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ChemPartner PharmaTech
83%
WuXi Biologics
82%
MabPlex
82%

Taichu Group Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 1, 2025
Series A ExtensionMar 8, 2024
Series AMay 8, 2023
Pre SeedAug 15, 2022
AngelJul 18, 2022
Seed
Oct 28, 2020

Taichu Group Investors

Notable investors and investment history

Taichu Group investors
InvestorRounds
IDG CapitalSeries A
TF CapitalAngel
上实投资(上海)有限公司Seed
Tigeryeah CapitalSeries A Extension
Yijing CapitalSeries A
Fortera CapitalSeries A Extension
Juntong CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2025

    Completed a Series B funding round.

  • May 8, 2023

    $57M round led by IDG Capital

Taichu Group Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Taichu Group Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Taichu Group's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Year Founded2020
Last FundingMar 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.